Clinical efficacy of risperidone in idiopathic segmental dystonia

Author： Zuddas A.   Carta M.   Muglia P.   DeMontis N.   Cianchetti C.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 349-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risperidone: Tardive dystonia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1311, 2010-01 ,pp. : 36-36

Adis International

Access to resources Recommend Favorite

Risperidone: Tardive pharyngeal dystonia: case report

By  

Reactions Weekly, Vol. 1, Iss. 1219, 2008-01 ,pp. : 28-28

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Profile and Clinical Efficacy of Long-Acting Risperidone: Potential Benefits of Combining an Atypical Antipsychotic and a New Delivery System

By Ereshefsky Larry  

Drugs in R&D, Vol. 6, Iss. 3, 2005-01 ,pp. : 129-137

Adis International

Access to resources Recommend Favorite

Pharmacology and clinical experience with risperidone

By Love R.C.   Nelson M.W.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 7, 2000-12 ,pp. : 1441-1453

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of clinical response to risperidone

By LLerena Adrián   Berecz Roland   Peñas-LLedó Eva   Süveges Ágnes   Fariñas Humberto  

Pharmacogenomics, Vol. 14, Iss. 2, 2013-01 ,pp. : 177-194

Future Medicine

Access to resources Recommend Favorite